30 April 2020
Warning & Withdrawals of Health-related Products
Reference: CIR-2019-00000289
To all health facilities / all health care practitioners in Dubai's private health sector:
Referring to the above subject, DHA notes all health facilities regarding the Circular issued by the MOHAP for information and adhere to what is stated
- Warning regarding using pharmaceutical product
- Recall & Suspension of registration of pharmaceutical product Gupisone Syrup
- Recall specific batch’s of medical device BD Microtainer K2E tubes
- Safety alerts from using the Nutritional supplements Passion Classic Maximum Power, Red Lips Premium Triple Maximum
- Withdrawal of the complaint concerning medical device
- Safety update of pharmaceutical product Blincyto (Blinatumomab)
Thanks in advance for your good co-operation
Drug Control Section
Health Regulation Sector
DHA
Supporting Documents:
Warning regarding using pharmaceutical product.pdf:
View Document
pot. chloride MHRA.pdf:
View Document
Recall _ Suspension of registration of pharmaceutical product Gupisone Syrup.pdf:
View Document
Recall specific batchs of medical device BD Microtainer K2E tubes.pdf:
View Document
Safety alerts from using the Nutritional supplements Passion Classic Maximum Power Red Lips Premium Triple Maximum.pdf:
View Document
Withdrawal of the complaint concerning medical device.pdf:
View Document
Safety update of pharmaceutical product Blincyto (Blinatumomab).pdf:
View Document
